Journals / Maltepe Tıp Dergisi / 2021 / Cilt: 13 - Sayı: 3

Mild/moderate and severe COVID-19 pneumonia: Can the clinical course be predicted?

Hafif/orta ve ağır COVID-19 pnömonisi: klinik seyri öngörmek mümkün mü?

Pages
92–96
Publication Date
2021-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our results emphasized that COVID-19 pneumonia may show a severe clinical course in patients presented with dyspnea without hypoxia and had elevated leukocyte count, CRP, and D-dimer values.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, it was aimed to compare clinical and laboratory characteristics of cases with mild/moderate or severe COVID-19 pneumonia and to identify factors related to severe disease.
📊
Key Findings & Data:Methods: We retrospectively reviewed the clinical and laboratory characteristics of adult patients who were hospitalized with a diagnosis of COVID-19 pneumonia.
💡
Conclusion & Impact:Conclusion: Our results emphasized that COVID-19 pneumonia may show a severe clinical course in patients presented with dyspnea without hypoxia and had elevated leukocyte count, CRP, and D-dimer values.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Covid-19 · Pnömoni · SARS-CoV-2

Abstract

Objective: In this study, it was aimed to compare clinical and laboratory characteristics of cases with mild/moderate or severe COVID-19 pneumonia and to identify factors related to severe disease. Methods: We retrospectively reviewed the clinical and laboratory characteristics of adult patients who were hospitalized with a diagnosis of COVID-19 pneumonia. The study included patients in whom SARS-CoV-2 nucleic acid was found by real-time polymerase chain reaction (RT-PCR) and pneumonia was detected chest computed tomography scan. Results: Of 94 patients (41 women, 53 men), 71 were classified as mild/moderate pneumonia while 23 were classified as severe pneumonia. Mean age was significantly higher in severe pneumonia group (p<0.001). Cough and dyspnea were most common complaints at presentation (53% and 44%, respectively). In multivariate logistic regression analysis, dyspnea (OR: 13.24; 95% CI: 1.14-153.12; p: 0.39), leukocytosis (OR: 1.29; %95 CI: 1.08-1.55; p: 0.006), CRP elevation (OR: 1.01; 95% CI: 1.00-1.02; p: 0.006) and D-dimer elevation (OR: 1.80; 95%:1.15-2.81; p: 0.01) were identified as independent factors related to severe pneumonia. Conclusion: Our results emphasized that COVID-19 pneumonia may show a severe clinical course in patients presented with dyspnea without hypoxia and had elevated leukocyte count, CRP, and D-dimer values.

Özet

Amaç: Bu çalışmada hafif/orta ve ağır pnömoni gelişen olgulardaki klinik ve laboratuvar özelliklerin karşılaştırılması ve ağır seyir ile ilişkili olan faktörlerin saptanması amaçlandı. Yöntemler: COVID-19 pnömoni tanısıyla hastaneye yatırılan erişkin hastaların klinik ve laboratuvar özellikleri geriye dönük olarak incelendi. Çalışmaya gerçek zamanlı polimeraz zincir reaksiyonu (RT-PCR) ile SARS-CoV-2 nükleik asidi bulunan ve akciğer bilgisayarlı tomografisinde pnömoni saptanan hastalar dahil edildi. Bulgular: Çalışmaya alınan 94 (41’i kadın ve 53’ü erkek) olgudan 71’i hafif/orta pnömoni olarak tanımlanırken 23’ü ağır pnömoni olarak sınıflandırıldı. Ağır pnömoni grubunda yaş ortalaması belirgin olarak daha yüksek bulundu (p<0.001). Başvuru esnasında öksürük ve nefes darlığı en sık (sırasıyla %53, %44) saptanan yakınmalar idi. Yapılan çok değişkenli lojistik regresyon analizinde nefes darlığı (p:0.039, OR:13.24, %95CI: 1.14-153.12), lökositoz (p=0.006, OR: 1.29, %95CI: 1.08-1.55), CRP yüksekliği (p=0.006, OR: 1.01, %95CI: 1.00-1.02) ve D-dimer yüksekliği (p=0.01, OR:1.80 %95CI: 1.15-2.81) ağır pnömoni için bağımsız risk faktörü olarak saptandı. Sonuç: Çalışma sonuçları, başvuru esnasında hipoksi olmadan nefes darlığı yakınması olan, lökosit, CRP ve D-dimer değerleri yüksek olan hastalarda, COVID-19 pnömonisinin ağır seyredebileceğine dikkat çekmiştir

🔖

Cite This Article

HAMİDİ, A. A., ULU, Y. (2021). Mild/moderate and severe COVID-19 pneumonia: Can the clinical course be predicted?. Maltepe Tıp Dergisi, Cilt: 13 - Sayı: 3, 92–96. https://ajindex.com/articles/385637

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506
  2. Coronaviridae Study Group of the International Committee on Taxonomy of V. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536-44
  3. Demirbilek Y, Pehlivanturk G, Ozguler ZO, Alp Mese E. COVID-19 outbreak control, example of ministry of health of Turkey. Turk J Med Sci. 2020;50(SI-1):489-94
  4. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020
  5. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13
  6. Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020
  7. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020
  8. Organization. WH. Estimating mortality from COVID-19 2020 [Available from:
  9. Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia. Invest Radiol. 2020;55(6):327-31
  10. Lyu P, Liu X, Zhang R, Shi L, Gao J. The Performance of Chest CT in Evaluating the Clinical Severity of COVID-19 Pneumonia: Identifying Critical Cases Based on CT Characteristics. Invest Radiol. 2020;55(7):412-21
  11. Guillo E, Bedmar Gomez I, Dangeard S, Bennani S, Saab I, Tordjman M, et al. COVID-19 pneumonia: Diagnostic and prognostic role of CT based on a retrospective analysis of 214 consecutive patients from Paris, France. Eur J Radiol. 2020;131:109209
  12. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67
  13. Li X, Xu S, Yu M